Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

Initial experience and patient tolerance of proton stereotactic body radiotherapy.

29/10/2024
/ Publications
/
Hypofractionation

This study reported treatment outcomes of 52 patients (62 lesions) treated with proton SBRT. Fractionation varied by indication and site with a median of 5...

Quantifying dose uncertainties resulting from cardiorespiratory motion in intensity-modulated proton therapy for cardiac stereotactic body radiotherapy.

29/10/2024
/ Publications
/
Hypofractionation
Motion Management

This study from China investigated dose uncertainties induced by cardiorespiratory motion in proton therapy for arrhythmia. Twelve patients with refractory...

Empowering Cancer Care with Proton Therapy

13/11/2024
/ Webinar
/
Reirradiation
Hypofractionation
Immunotherapy

This webinar provides invaluable insights from the leading experts sharing their expertise on the clinical benefits of Proton Therapy compared to conventional...

Long-term Outcomes from Proton Therapy for Sinonasal Cancers

08/06/2021
/ Publications
/
Hypofractionation
Chemotherapy
Survival

A study by the Jacksonville group reported clinical outcomes of 143 patients with nonmetastatic sinonasal cancers treated with primary (18%; n = 26) or adjuvant...

Treatment outcomes of passive scattering proton beam therapy for stage I non-small cell lung cancer

08/08/2021
/ Publications
/
Hypofractionation
Toxicity

A study by the NCC, Korea group. This study retrospectively analyzed 42 patients with stage I NSCLC treated with protos to an initial dose of 60 CGE in 4...

Hypofractionated Proton Therapy in Early Prostate Cancer: Results of a Phase I/II Trial at Loma Linda University.

11/08/2019
/ Publications
/
Hypofractionation

A cohort of 146 patients with low-risk prostate cancer were treated to 60 Gy (cobalt Gy equivalent) of proton therapy (20 fractions of 3.0 Gy per fraction) in 4...

High-dose conformal proton therapy for clinical perineural invasion in cutaneous head and neck cancer.

11/12/2019
/ Publications
/
Hypofractionation

Perineural invasion (PNI) is an uncommon (<5%) which refers to tumor cell invasion extensive enough to cause clinically detectable deficits of the involved...

Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma.

11/12/2019
/ Publications
/
Hypofractionation
Survival

This study by MGH retrospectively analyzed 66 patients with unresectable intrahepatic cholangiocarcinoma (ICC) who were treated with hypofractionated proton (32...

Proton beam radiotherapy for pancreas cancer.

03/02/2020
/ Publications
/
Hypofractionation
Chemotherapy

A review article examined up to date data of PBT for pancreatic cancer. For both resectable and unresectable pancreatic cancer, the clinical outcome data is...

Proton beam radiotherapy for anal and rectal cancers.

03/02/2020
/ Publications
/
Hypofractionation

A review article looked at the current status of PBT for anal and rectal cancers. PBT offers appealing potential to reduce toxicity, increase patient compliance...